|   |   | 
Legal status
Patent not validated
| (51) | INT.CL. | A61N 2/02 | |
| A61N 2/00 | 
| (11) | Number of the document | 2814569 | 
| (13) | Kind of document | T | 
| (96) | European patent application number | 13748474.7 | 
| Date of filing the European patent application | 2013-02-13 | |
| (97) | Date of publication of the European application | 2014-12-24 | 
| (45) | Date of publication and mention of the grant of the patent | 2018-10-24 | 
| (46) | Date of publication of the claims translation | 
| (86) | Number | PCT/IB2013/051171 | 
| Date | 2013-02-13 | 
| (87) | Number | WO 2013/121359 | 
| Date | 2013-08-22 | 
| (30) | Number | Date | Country code | 
| 201261597850 P | 2012-02-13 | US | 
| (72) | 
                    
                    
                    
                    
                    PELL, Gaby, IL  
                    
                    
                    
                    
                    ZANGEN, Abraham, IL  
                    
                    
                    
                    
                    ROTH, Yiftach, IL  | 
| (73) | Brainsway, Ltd.,
                19 Hartum Street  P.O.B. 45169, 9777518 Jerusalem,
                IL | 
| (54) | TRANSCRANIAL MAGNETIC STIMULATION TO MODULATE PERMEABILITY OF THE BLOOD-BRAIN BARRIER | 
| TRANSCRANIAL MAGNETIC STIMULATION TO MODULATE PERMEABILITY OF THE BLOOD-BRAIN BARRIER |